Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early high-dose versus late low-dose aspirin after CABG
2006-000024-13Phase 4Completed
- Sponsor
- Cardiff and Vale University Health Board
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin in coronary arteriosclerosis (2 arms), sponsored by Cardiff and Vale University Health Board. Primary endpoint: Effect of aspirin on platelet function. Started Feb 2006; status: completed.
02
Drugs
aspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2006-000024-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000024-13.